tiprankstipranks
Ondine Biomedical, Inc. (GB:OBI)
LSE:OBI
UK Market
Want to see GB:OBI full AI Analyst Report?

Ondine Biomedical, Inc. (OBI) Financial Statements

13 Followers

Ondine Biomedical, Inc. Financial Overview

Ondine Biomedical, Inc.'s market cap is currently £68.68M. The company's EPS TTM is p-0.064; its P/E ratio is -4.42; Ondine Biomedical, Inc. is scheduled to report earnings on June 4, 2026, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 2.65MC$ 2.05MC$ 1.20MC$ 638.00KC$ 2.57M
Gross ProfitC$ 1.09MC$ 1.32MC$ 703.00KC$ 287.00KC$ 1.25M
Operating IncomeC$ -30.04MC$ -19.44MC$ -14.80MC$ -18.76MC$ -17.52M
EBITDAC$ -29.45MC$ -18.49MC$ -13.79MC$ -18.85MC$ -48.36M
Net IncomeC$ -29.59MC$ -19.10MC$ -14.41MC$ -19.37MC$ -50.09M
Balance Sheet
Cash & Short-Term InvestmentsC$ 10.58MC$ 9.77MC$ 2.98MC$ 13.13MC$ 30.36M
Total AssetsC$ 14.40MC$ 12.82MC$ 5.73MC$ 16.57MC$ 34.14M
Total DebtC$ 413.50KC$ 168.00KC$ 541.00KC$ 896.00KC$ 739.00K
Net DebtC$ -10.17MC$ -9.60MC$ -2.44MC$ -12.23MC$ -29.63M
Total LiabilitiesC$ 10.91MC$ 5.95MC$ 3.65MC$ 4.92MC$ 4.48M
Stockholders' EquityC$ 3.49MC$ 6.88MC$ 2.08MC$ 11.64MC$ 29.66M
Cash Flow
Free Cash FlowC$ -24.02MC$ -15.50MC$ -13.83MC$ -16.66MC$ -12.62M
Operating Cash FlowC$ -23.90MC$ -15.49MC$ -13.65MC$ -16.34MC$ -12.54M
Investing Cash FlowC$ -117.28KC$ -10.00KC$ -177.00KC$ -311.00KC$ -77.00K
Financing Cash FlowC$ 24.28MC$ 21.74MC$ 3.79MC$ -275.00KC$ 41.90M
Currency in CAD

Ondine Biomedical, Inc. Earnings and Revenue History

Ondine Biomedical, Inc. Debt to Assets

Ondine Biomedical, Inc. Cash Flow

Ondine Biomedical, Inc. Forecast EPS vs Actual EPS